THG issues profit warning as it sells nutrition product supplier

THG Studios building

In a trading update on its first half performance, THG said adjusted EBITDA would be £24m, down from £37.1m in 2024, which reflected “substantially higher whey pricing year on year” for its nutrition arm.

 

Already have an account?

Want to read more?

Register for LIMITED guest access

Register now

Get premium access

£5 A MONTH for 3 months

Subscribe now